Featured Videos |view more
Minoo Kavarana, M.D., a pediatric cardiothoracic surgeon at MUSC, discusses a new procedure. By placing a reversible pulmonary artery band around a child’s pulmonary artery, surgeons are able to help patients survive longer while they ...
Featured Articles and Documents |view more
In recent years, improved mechanical circulatory support devices have become available that can significantly extend the lives of heart failure patients.
MUSC researchers recently published results from a Phase II clinical trial for a novel, oral ATTR-CM therapy called AG10, that was found to be highly effective in halting disease progression.
Results from the COAPT study showed that patients who received the MitraClip® procedure had significantly lower hospitalizations for heart failure within two years compared to those who received standard care.
Cardiovascular genetic testing can improve diagnostic precision and clinical decision-making and provide a patient's family members with potentially life-saving information.
The MUSC Health Heart and Vascular Center offers more heart disease specialists and treatment options and treats more heart patients than any other medical center in the state.Treating such a high volume of patients has deepened our expertise and led to outstanding outcomes. Our rates of complications and hospital readmissions are lower than national averages. Our nationally recognized specialists share their experience and knowledge with cardiologists from around the world and also teach the next generation of heart experts who receive training in cardiology and cardiac surgery right here at MUSC Health. As South Carolina’s only medical research and training institution, we are able to offer patients the chance to participate in clinical research projects including clinical trials of new drugs, devices and approaches to heart disease.